FANJ
FLXN

Financial Architects (New Jersey)’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Financial Architects (New Jersey)’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-400
Closed -$5K – 1025
2019
Q3 		$5K Hold
400
– – ﹤0.01% 836
2019
Q2 		$5K Buy
+400
New +$4.62K ﹤0.01% 1016
2018
Q1 		– Sell
-200
Closed -$5K – 1641
2017
Q4 		$5K Buy
+200
New +$4.9K ﹤0.01% 1313

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Financial Architects (New Jersey)'s FLXN Position: Q4 2019 in Review

Financial Architects (New Jersey) sold out of Flexion Therapeutics, Inc. (FLXN) in Q4 2019, closing a stake of 400 shares — an estimated $5K sold.

Financial Architects (New Jersey) first reported a position in FLXN in Q4 2017 and held it in 3 quarters. The position peaked at $5K in Q3 2019. 133 funds tracked by Wall St. Rank hold FLXN as of Q4 2019.

  • Financial Architects (New Jersey) reported no remaining Flexion Therapeutics, Inc. position as of Q4 2019 after selling out during the quarter.
  • Financial Architects (New Jersey) sold 400 Flexion Therapeutics, Inc. shares in Q4 2019, an estimated $5K.
  • Financial Architects (New Jersey) first reported a position in Flexion Therapeutics, Inc. in Q4 2017 and held it in 3 quarters.
  • Financial Architects (New Jersey)'s Flexion Therapeutics, Inc. position peaked at $5K in Q3 2019.
  • 133 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q4 2019.

Based on Financial Architects (New Jersey)'s 13F filing for Q4 2019, filed 14 Feb 2020.